ScholarIQanswers from OpenAlex
Galectins and Cancer Biology
TopicLeading institutions, researchers & key papers
Galectins and Cancer Biology is a topic indexed in ScholarIQ from OpenAlex.
What is known about Galectins and Cancer Biology?
ScholarIQrecord summary
This cluster of papers explores the diverse roles of galectins in immune regulation, inflammation, cancer, macrophage activation, T cell dysfunction, fibrosis, angiogenesis, heart failure, and autoimmunity. Galectins are implicated in modulating various aspects of immune responses and have potential implications for therapeutic interventions in a range of diseases.
How many works does Galectins and Cancer Biology have?
ScholarIQindexed works
Galectins and Cancer Biology has 183 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Galectins and Cancer Biology?
ScholarIQopenalex
The OpenAlex for Galectins and Cancer Biology is on the source record.
What are the most-cited papers on Galectins and Cancer Biology?
ScholarIQmost cited works
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Lasse Folkersen, Stefan Gustafsson, Qin Wang, Daniel Hvidberg Hansen, Åsa K. Hedman, Andrew J. Schork, Karen Page, Daria V. Zhernakova, Yang Wu, James E. Peters, Niclas Eriksson, Sarah E. Bergen, Thibaud Boutin, Andrew D. Bretherick, Stefan Enroth, Anette Kalnapenkis, Jesper R. Gådin, Bianca E Suur, Yan Chen, Ljubica Matic, Jeremy D. Gale, Julie Lee, Weidong Zhang, Amira Quazi, Mika Ala‐Korpela, Seung Hoan Choi, Annique Claringbould, John Danesh, George Davey Smith, Federico De Masi, Sölve Elmståhl, Gunnar Engström, Eric B. Fauman, Céline Fernandez, Lude Franke, Paul W. Franks, Vilmantas Giedraitis, Chris Haley, Anders Hamsten, Andrés Ingason, Åsa Johansson, Peter K. Joshi, Lars Lind, Cecilia M. Lindgren, Steven A. Lubitz, Tom Palmer, Erin Macdonald-Dunlop, Martin Magnusson, Olle Melander, Karl Michaëlsson, Andrew P. Morris, Reedik Mägi, Michael W. Nagle, Peter M. Nilsson, Jan Nilsson, Marju Orho‐Melander, Ozren Polašek, Bram P. Prins, Erik Pålsson, Ting Qi, Marketa Sjögren, Johan Sundström, Praveen Surendran, Urmo Võsa, Thomas Werge, Rasmus Wernersson, Harm-Jan Westra, Jian Yang, Alexandra Zhernakova, Johan Ärnlöv, Jingyuan Fu, J. G. Smith, Tõnu Esko, Caroline Hayward, Ulf Gyllensten, Mikael Landén, Agneta Siegbahn, James F. Wilson, Lars Wallentin, Adam S. Butterworth, Michael V. Holmes, Erik Ingelsson, Anders Mälarstig
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E. Kim, Mira Patel, Antonella Mangraviti, Eileen Kim, Debebe Theodros, Esteban Velarde, Ann Liu, Eric W. Sankey, Ada Tam, Haiying Xu, Dimitrios Mathios, Christopher M. Jackson, Sarah Harris‐Bookman, Tomás Garzón-Muvdi, Mary Sheu, Allison Martin, Betty Tyler, Phuoc T. Tran, Xiaobu Ye, Alessandro Olivi, Janis M. Taube, Peter C. Burger, Charles G. Drake, Henry Brem, Drew M. Pardoll, Michael Lim
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu, Willem P.T. Ruifrok, Maxi Meissner, Eelke M. Bos, Harry van Goor, Bahram Sanjabi, Pim van der Harst, Bertram Pitt, Irwin Goldstein, Jasper Koerts, Dirk J. van Veldhuisen, Ruud A. Bank, Wiek H. van Gilst, Herman H.W. Silljé, Rudolf A. de Boer
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier, María Miana, Pascal Reboul, Victoria Cachofeiro, Ernesto Martínez‐Martínez, Rudolf A. de Boer, Françoise Poirier, Patrick Lacolley, Faı̈ez Zannad, Patrick Rossignol, Natalia López‐Andrés
Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin
Jun Wada, Yashpal S. Kanwar
Where is Galectins and Cancer Biology research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Galectins and Cancer Biology is open access?
ScholarIQopen access share
73%OPEN ACCESS